Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations.
Front Immunol
; 13: 873195, 2022.
Article
in En
| MEDLINE
| ID: mdl-35757699
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rheumatic Diseases
/
Antirheumatic Agents
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Journal:
Front Immunol
Year:
2022
Type:
Article
Affiliation country:
Italy